Silver Book Fact

Medicare patients with sSAS have an average lifespan of 1.8 years without repair or replacement

Fact image

Goel S, Bajaj N, Agaarwall B, et al. Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure. J Am Coll Cardiol. 2014; 63(2). http://www.onlinejacc.org/content/63/2/185

Reference

Title
Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure
Publication
J Am Coll Cardiol
Publication Date
2014
Authors
Goel S, Bajaj N, Agaarwall B, et al
Volume & Issue
Volume 63, Issue 2
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • Aortic stenosis often undertreated
     
  • Lifespan of Medicare patients with sSAS who do not undergo treatment
    Medicare patients with severe symptomatic aortic stenosis (sSAS) who do not undergo treatment have an average lifespan of 1.8 years.  
  • 1 and 6-month mortality rates without treatment for sSAS
    Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).  
  • Survival rates for SAS patients without treatment
     
  • Five-year health care resource use in medically managed SAS patients